F2G

1 follower

‌

F2G is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat life-threatening invasive fungal infections.

Industries

Biotechnology

Headquarters

Manchester, United Kingdom

Employees

51-200

Links

Org chart

Francesco Maria Lavino

CEO

Francesco Maria Lavino

Collapse

Ralf Schmid

CFO

John H. Rex

Chief Medical Officer

Mike Birch

COO

Tony Kennedy

Chief Scientific & Development Officer

Janelle R. Anderson

Chief Business Officer

Mark Baglin

Chief Commercial Officer

Ana Zaccaro

Vice President Regulatory Affairs

daniela zinzi

VP, Clinical R&D

Dean Thompson

Director, Analytical Development

Mark Bresnik, MD

Executive Director, Clinical R&D

Karen Cornelissen

Director Early Clinical Development

Sufyaan Bhamjee

In-House Counsel

Teams

Medical Affairs and Clinical Operations

12 members

Leadership Team

7 members

Science and Research Team

7 members

Similar companies

REVOLUTION Medicines

5 followers

Stemline Therapeutics

3 followers

Emulate

1 follower

Immunocore

1 follower

Biosynth

1 follower

OpenBiome

1 follower

eLife

11 followers

Erevena

6 followers

QuellTX

4 followers

Sum & Substance

3 followers

Nucleate

3 followers

Explore companies